These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 21536855

  • 1. Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure.
    Ng TM, Ackerbauer KA, Hyderi AF, Hshieh S, Elkayam U.
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):79-85. PubMed ID: 21536855
    [Abstract] [Full Text] [Related]

  • 2. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, Gottlieb SS, O'Connor CM, Starling RC, Tang WH, McMurray JJ, Dickstein K, Voors AA.
    Circulation; 2014 Sep 16; 130(12):958-65. PubMed ID: 25074507
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM, Hshieh S, Chan CY, Elkayam U.
    J Cardiovasc Pharmacol Ther; 2012 Dec 16; 17(4):373-81. PubMed ID: 22610091
    [Abstract] [Full Text] [Related]

  • 4. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ, Dowling TC, Meadows D, Ayala T, Marshall J, Minshall S, Greenberg N, Thattassery E, Fisher ML, Rao K, Gottlieb SS.
    Circulation; 2004 Sep 21; 110(12):1620-5. PubMed ID: 15337695
    [Abstract] [Full Text] [Related]

  • 5. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients.
    Chow SL, Peng JT, Okamoto MP, Heywood JT.
    Ann Pharmacother; 2007 Apr 21; 41(4):556-61. PubMed ID: 17389662
    [Abstract] [Full Text] [Related]

  • 6. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 7. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS, Stebbins A, Voors AA, Hasselblad V, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Hernandez AF.
    J Am Coll Cardiol; 2013 Sep 24; 62(13):1177-83. PubMed ID: 23747790
    [Abstract] [Full Text] [Related]

  • 8. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
    Miller WL, Kurien S, Warfield KT, Wood CM, Jaffe AS.
    Int J Cardiol; 2008 May 23; 126(2):234-9. PubMed ID: 17482692
    [Abstract] [Full Text] [Related]

  • 9. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.
    Chow SL, O'Barr SA, Peng J, Chew E, Pak F, Quist R, Patel P, Patterson JH, Heywood JT.
    J Card Fail; 2011 Mar 23; 17(3):181-7. PubMed ID: 21362524
    [Abstract] [Full Text] [Related]

  • 10. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
    Arora S, Clarke K, Srinivasan V, Gradman A.
    QJM; 2007 Nov 23; 100(11):699-706. PubMed ID: 17971392
    [Abstract] [Full Text] [Related]

  • 11. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
    Ejaz AA, Martin TD, Johnson RJ, Winterstein AG, Klodell CT, Hess PJ, Ali AK, Whidden EM, Staples NL, Alexander JA, House-Fancher MA, Beaver TM.
    J Thorac Cardiovasc Surg; 2009 Oct 23; 138(4):959-64. PubMed ID: 19660420
    [Abstract] [Full Text] [Related]

  • 12. Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide).
    Iglesias J, Hom D, Antoniotti M, Ayoub S, Levine JS.
    Nephrol Dial Transplant; 2006 Dec 23; 21(12):3458-65. PubMed ID: 16877484
    [Abstract] [Full Text] [Related]

  • 13. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction.
    Kelesidis I, Mazurek J, Khullar P, Saeed W, Vittorio T, Zolty R.
    Congest Heart Fail; 2012 Dec 23; 18(3):158-64. PubMed ID: 22497779
    [Abstract] [Full Text] [Related]

  • 14. Renal function trajectories and clinical outcomes in acute heart failure.
    Givertz MM, Postmus D, Hillege HL, Mansoor GA, Massie BM, Davison BA, Ponikowski P, Metra M, Teerlink JR, Cleland JG, Dittrich HC, O'Connor CM, Cotter G, Voors AA.
    Circ Heart Fail; 2014 Jan 23; 7(1):59-67. PubMed ID: 24281137
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
    Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF).
    JAMA; 2002 Mar 27; 287(12):1531-40. PubMed ID: 11911755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J, ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group.
    J Am Coll Cardiol; 2005 Jul 05; 46(1):57-64. PubMed ID: 15992636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.